Please click here to view the recording This interactive webinar will feature a panel of experienced nurses who work in different fields and will examine the ongoing potential of PrEP in HIV prevention in Australia. Learn about the role of primary care in the latest epidemiological trends in HIV, current patient demographics, effectiveness of PrEP […]
This recorded webinar features a panel of experienced GPs examining the role of PrEP in HIV prevention in Australia. It covers current epidemiological trends, patient demographics, and the effectiveness of PrEP in reducing HIV transmission. A recording of this webinar is now available for on-demand viewing here. Learning outcomes Speakers Dr Elizabeth Leprince Dr […]
This resource is intended for use by patients who are being referred to their GP to initiate or continue PrEP. It provides clear instructions for GPs, including those who may be unfamiliar with PrEP prescribing.
Clinical Auditing and Case Finding Fundamentals is an eLearning course designed as an introduction to quality improvement (QI) and aims to support your understanding of the role and importance of QI within general practices. The module looks at the benefits of QI for the community, the practice and the patient, diving into fundamental principles and […]
This introduction to PrEP Prescribing online learning module has been developed to provide clinicians with an understanding of PrEP, including assessing a patient’s suitability for PrEP, how to prescribe it, and how to engage in ongoing monitoring of patients taking PrEP. It is intended for medical practitioners and nurse practitioners intending to prescribe PrEP, but […]
Enhance your PrEP prescribing decisions and contribute to the critical goal of HIV prevention with the Decision Making in PrEP resource. This invaluable 2-page tool is specifically designed for primary care providers, highlighting the crucial role of Pre-Exposure Prophylaxis (PrEP) in reducing the transmission of HIV. By engaging with this resource, healthcare professionals can deepen […]
Discover the updated 2025 Australian PrEP Guidelines, a comprehensive online resource for healthcare professionals. These guidelines have undergone rigorous review and updating by the PrEP Guidelines Panel and the PrEP Guidelines Reviewing Committee. They provide essential recommendations to support clinicians in prescribing PrEP using approved coformulated tenofovir and emtricitabine medications, as well as bioequivalent generic […]
The PrEP dosing guide is intended to help clinicians in making the decision whether daily PrEP or on-demand PrEP is suitable for the patient.This resource also gives examples of the different dosing options and explains how to prescribe it.
On the 6th of April 2024, ASHM Health organised a national workshop, funded by ViiV Healthcare, to convene a select group of key stakeholders from each Australian state and territory. The primary objective was to facilitate discussions around how to successfully implement the use of long-acting injectable cabotegravir (CAB-LA) as HIV PrEP throughout Australia and to identify […]
As of 9 September 2024, Australia is currently experiencing a supply shortage of medications containing tenofovir and emtricitabine, which are commonly used for HIV Pre-Exposure Prophylaxis (PrEP). Despite this shortage, pharmacists, HIV PrEP prescribers, and people using HIV PrEP should not be alarmed — shortages are expected to resolve later this year for most brands. Current impact […]
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2024 ASHM